Astrazeneca PLC (AZN) Receives $38.59 Consensus Price Target from Analysts

Astrazeneca PLC (AZN) Receives $38.59 Consensus Price Target from Analysts


Astrazeneca PLC has been assigned a consensus rating of "Buy" from the twenty-two research firms that are covering the company. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the company.



from Biotech News